Type:
Educational Exhibit
Keywords:
Tissue characterisation, Pathology, Embolisation, Complications, MR-Diffusion/Perfusion, MR-Angiography, MR, Pelvis, Interventional vascular, Genital / Reproductive system female
Authors:
I. Kavelj, L. Novosel, K. Bolanca, N. BABIC, D. Zadravec; Zagreb/HR
DOI:
10.26044/ecr2019/C-3564
References
1. Deshmukh SP,
Gonsalves CF,
Guglielmo FF,
Mitchell DG.
Role of MR imaging of uterine leiomyomas before and after embolization.
Radiographics 2012 Oct;32(6):E251-E281.
doi: 10.1148/rg.326125517.
2. Murase E,
Siegelman ES,
Outwater EK,
Perez-Jaffe LA,
Tureck RW. Uterine leiomyomas: histopathologic features,
MR imaging findings,
differential diagnosis,
and treatment. Radiographics.
1999 Sep-Oct;19(5):1179-1197.
3. Cura M,
Cura A,
Bugnone A.
(2006).
Role of magnetic resonance imaging in patient selection for uterine artery embolization.
Acta Radiologica,
47(10),
1105–1114.
https://doi.org/10.1080/02841850600965047.
4.
Duc NM,
Huy HQ. Effect of magnetic resonance imaging characteristics on uterine fibroid treatment.
Reports in Medical Imaging 2018;11:1–8.
5.
Foti PV,
Tilocca C,
Sigona A,
Palmucci S,
Farina R,
Caltabiano R,
Spadola S,
Zarbo G,
Zarbo R,
Milone P,
Ettorre GC.
Benign neoplasms of the uterus: MR imaging of leiomyomas with radiologic-pathologic correlation.
WCRJ 2015; 2 (2): e516.
6. Sala E,
Freeman S.
Structured reporting of pelvic MRI leads to better treatment planning of uterine leiomyomas.
Eur Radiol.
2018 Jul;28(7):3007-3008.
doi: 10.1007/s00330-018-5417-z.